Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)

AIM: Talimogene laherparepvec (T-VEC) is an intralesional therapy for unresectable, metastatic melanoma. T-VEC real-world use in the context of anti-PD1-based therapy requires further characterization. MATERIALS & METHODS: A retrospective review of T-VEC use from 1 January 2017 and 31 March 2018...

Full description

Saved in:
Bibliographic Details
Published in:Melanoma Manag
Main Authors: Sun, James, Gastman, Brian R, McCahon, Lucy, Buchbinder, Elizabeth I, Puzanov, Igor, Nanni, Michele, Lewis, James M, Carvajal, Richard D, Singh-Kandah, Shahnaz, Desai, Anupam M, Raskin, Leon, Nielson, Carrie M, Ismail, Rubina, Zager, Jonathan S
Format: Artigo
Language:Inglês
Published: Future Medicine Ltd 2020
Subjects:
Short Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7426742/
https://ncbi.nlm.nih.gov/pubmed/32821373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2020-0005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items